Company / Depreciation & Amortization
Nuvation Bio Inc. Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.7M
FY2025
5-year range
$184.0K / $1.7M
FY2021-FY2025
Trend
+154.6%
vs FY2024
Sector context
#105 of 168
Health Care
What the data says
At $2M, Nuvation Bio Inc.'s depreciation & amortization ranks #64 of 168 in the Health Care sector. Depreciation & Amortization has increased for 5 consecutive years, from $103,000 in FY2020 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +76.0%.
Increased from $222,000 to $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +106.0%
- 5-Year CAGR
- +76.0%
- 10-Year CAGR
- -
Sector benchmark
#64 of 168 in Health CareTop 38% of 168This company $1.7M Sector average $212.9M
▼
-99.2% below sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s depreciation & amortization has grown for 5 consecutive years.
- 5-year CAGR of +76.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 154.6% year-over-year.
- Ranks #105 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7M | +154.6% |
| FY2024 | $683.0K | +207.7% |
| FY2023 | $222.0K | +11.6% |
| FY2022 | $199.0K | +8.2% |
| FY2021 | $184.0K | +78.6% |
| FY2020 | $103.0K | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026